Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Genomic analysis of metastatic rhabdomyosarcoma masquerading as acute leukemia.

Pasvolsky O, Heiman L, Popovtzer A, Zimra Y, Rabizadeh E, Barshack I, Mardoukh C, Raanani P, Rozovski U.

Pathol Res Pract. 2020 Jan;216(1):152779. doi: 10.1016/j.prp.2019.152779. Epub 2019 Dec 2.

PMID:
31813602
2.

Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.

Shimony S, Horowitz N, Ribakovsky E, Rozovski U, Avigdor A, Zloto K, Berger T, Avivi I, Perry C, Abadi U, Raanani P, Gafter-Gvili A, Gurion R.

Hematol Oncol. 2019 Dec;37(5):569-577. doi: 10.1002/hon.2691. Epub 2019 Nov 25.

PMID:
31674027
3.

STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Uziel O, Keating MJ, Estrov Z.

J Immunol. 2019 Dec 1;203(11):3078-3085. doi: 10.4049/jimmunol.1900389. Epub 2019 Oct 23.

PMID:
31645416
4.

Indications for genetic testing leading to termination of pregnancy.

Svirsky R, Pekar-Zlotin M, Rozovski U, Maymon R.

Arch Gynecol Obstet. 2019 Nov;300(5):1221-1225. doi: 10.1007/s00404-019-05289-4. Epub 2019 Sep 16.

PMID:
31529364
5.

Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.

Berger T, Rozovski U, Moshe Y, Yaari S, Frisch A, Hellmann I, Apel A, Aviram A, Koren-Michowitz M, Yeshurun M, Ram R, Raanani P, Ofran Y, Wolach O.

Ann Hematol. 2019 Dec;98(12):2711-2717. doi: 10.1007/s00277-019-03795-8. Epub 2019 Sep 11.

PMID:
31512015
6.

Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.

Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U.

Leuk Lymphoma. 2019 Dec;60(12):2922-2926. doi: 10.1080/10428194.2019.1620946. Epub 2019 Jun 6.

PMID:
31167584
7.

The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.

Shalem-Cohavi N, Beery E, Nordenberg J, Rozovski U, Raanani P, Lahav M, Uziel O.

Int J Mol Sci. 2019 May 21;20(10). pii: E2509. doi: 10.3390/ijms20102509.

8.

Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation.

Pasvolsky O, Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e343-e348. doi: 10.1016/j.clml.2019.03.007. Epub 2019 Mar 11.

PMID:
30948329
9.

Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms.

Barzilai M, Kirgner I, Avivi I, Ellis M, Dally N, Rozovski U, Lavi N.

Eur J Haematol. 2019 Jun;102(6):504-508. doi: 10.1111/ejh.13232. Epub 2019 Apr 25.

PMID:
30941804
10.

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Shargian-Alon L, Yahav D, Rozovski U, Dovrat S, Amitai I, Sela-Navon M, Pasvolsky O, Raanani P, Yeshurun M.

Leuk Lymphoma. 2019 Sep;60(9):2230-2236. doi: 10.1080/10428194.2019.1576869. Epub 2019 Feb 18.

PMID:
30773083
11.

Impaired lymphocyte reconstitution after autologous transplant is associated with apoptosis of CD8+ T cells and adverse clinical outcome.

Rozovski U, Naparstek E, Frank S, Fourman A, Zigman-Hoffman E, Bleiberg M, Yeshurun M, Trestman S, Tartakovsky B.

Leuk Lymphoma. 2019 Sep;60(9):2264-2270. doi: 10.1080/10428194.2018.1563696. Epub 2019 Jan 18.

PMID:
30656985
12.

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, Yeshurun M.

Acta Haematol. 2019;141(1):19-22. doi: 10.1159/000494423. Epub 2018 Nov 15.

PMID:
30439710
13.

The Effect of Ethanol on Telomere Dynamics and Regulation in Human Cells.

Harpaz T, Abumock H, Beery E, Edel Y, Lahav M, Rozovski U, Uziel O.

Cells. 2018 Oct 15;7(10). pii: E169. doi: 10.3390/cells7100169.

14.

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Oncotarget. 2018 Sep 14;9(72):33710-33718. doi: 10.18632/oncotarget.26110. eCollection 2018 Sep 14.

15.

Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?

Rozovski U, Keating MJ, Estrov Z.

Acta Haematol. 2018;140(1):51-54. doi: 10.1159/000491382. Epub 2018 Aug 16. Review.

16.

Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study.

Shacham-Abulafia A, Raanani P, Lavie D, Volchek Y, Ram R, Helman I, Shargian L, Gourevitch A, Chubar E, Ratzon R, Rozovski U.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e295-e301. doi: 10.1016/j.clml.2018.05.002. Epub 2018 May 7.

PMID:
29773429
17.

STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Oncotarget. 2018 Apr 20;9(30):21268-21280. doi: 10.18632/oncotarget.25066. eCollection 2018 Apr 20.

18.

MYC protein expression is an important prognostic factor in acute myeloid leukemia.

Ohanian M, Rozovski U, Kanagal-Shamanna R, Abruzzo LV, Loghavi S, Kadia T, Futreal A, Bhalla K, Zuo Z, Huh YO, Post SM, Ruvolo P, Garcia-Manero G, Andreeff M, Kornblau S, Borthakur G, Hu P, Medeiros LJ, Takahashi K, Hornbaker MJ, Zhang J, Nogueras-González GM, Huang X, Verstovsek S, Estrov Z, Pierce S, Ravandi F, Kantarjian HM, Bueso-Ramos CE, Cortes JE.

Leuk Lymphoma. 2019 Jan;60(1):37-48. doi: 10.1080/10428194.2018.1464158. Epub 2018 May 9.

19.

The genetic and clinical outcome of isolated fetal muscular ventricular septal defect (VSD).

Svirsky R, Brabbing-Goldstein D, Rozovski U, Kapusta L, Reches A, Yaron Y.

J Matern Fetal Neonatal Med. 2019 Sep;32(17):2837-2841. doi: 10.1080/14767058.2018.1449829. Epub 2018 Mar 20.

PMID:
29510647
20.

Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Leuk Lymphoma. 2018 Nov;59(11):2686-2691. doi: 10.1080/10428194.2018.1439167. Epub 2018 Feb 21.

21.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

22.

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Jain P, Nogueras González GM, Kanagal-Shamanna R, Rozovski U, Sarwari N, Tam C, Wierda WG, Thompson PA, Jain N, Luthra R, Quesada A, Sanchez-Petitto G, Ferrajoli A, Burger J, Kantarjian H, Cortes J, O'Brien S, Keating MJ, Estrov Z.

Br J Haematol. 2018 Jan;180(1):33-40. doi: 10.1111/bjh.15018. Epub 2017 Nov 21.

23.

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.

Joffe E, Rosenberg D, Rozovski U, Perry C, Kirgner I, Trestman S, Gur O, Aviv F, Sarid N, Kolomansky A, Gepstein L, Herishanu Y, Naparstek E.

Bone Marrow Transplant. 2018 Jan;53(1):29-33. doi: 10.1038/bmt.2017.205. Epub 2017 Oct 16.

PMID:
29035395
24.

Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Int J Cancer. 2017 Nov 15;141(10):2076-2081. doi: 10.1002/ijc.30892. Epub 2017 Aug 4.

25.

Outcomes of conception subsequent to methotrexate treatment for an unruptured ectopic pregnancy.

Svirsky R, Ben-Ami I, Berkovitch M, Halperin R, Rozovski U.

Int J Gynaecol Obstet. 2017 Nov;139(2):170-173. doi: 10.1002/ijgo.12264. Epub 2017 Aug 4.

PMID:
28710772
26.

Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.

Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF.

Neuro Oncol. 2017 May 1;19(5):660-668. doi: 10.1093/neuonc/now239.

27.

The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence.

Leader A, Zelikson-Saporta R, Pereg D, Spectre G, Rozovski U, Raanani P, Hermoni D, Lishner M.

Am J Med. 2017 Jul;130(7):826-832. doi: 10.1016/j.amjmed.2017.01.022. Epub 2017 Feb 14.

PMID:
28213047
28.

Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, O'Brien S, Bose P, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Mol Cancer Res. 2017 May;15(5):610-618. doi: 10.1158/1541-7786.MCR-16-0291. Epub 2017 Jan 27.

29.

Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.

Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z.

Lancet Haematol. 2017 Feb;4(2):e67-e74. doi: 10.1016/S2352-3026(16)30194-6. Epub 2017 Jan 12.

30.

Ocular extramedullary myeloid leukaemia.

Ohanian M, Pemmaraju N, Rozovski U, Alattar ML, Estrov Z, Kundra V, Tung C, Ravandi F, Manning J, Abruzzo LV.

Br J Haematol. 2018 Mar;180(5):738-740. doi: 10.1111/bjh.14430. Epub 2016 Nov 23. No abstract available.

PMID:
27879987
31.

Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia.

Jain P, Kanagal-Shamanna R, Wierda W, Keating M, Sarwari N, Rozovski U, Thompson P, Burger J, Kantarjian H, Patel KP, Medeiros LJ, Luthra R, Estrov Z.

Am J Hematol. 2016 Nov;91(11):E478-E479. doi: 10.1002/ajh.24496. Epub 2016 Aug 22. No abstract available.

32.

Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.

Chorin E, Hu D, Antzelevitch C, Hochstadt A, Belardinelli L, Zeltser D, Barajas-Martinez H, Rozovski U, Rosso R, Adler A, Benhorin J, Viskin S.

Circ Arrhythm Electrophysiol. 2016 Oct;9(10). pii: e004370.

33.

An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis.

Rozovski U, Verstovsek S, Manshouri T, Dembitz V, Bozinovic K, Newberry K, Zhang Y, Bove JE 4th, Pierce S, Kantarjian H, Estrov Z.

Haematologica. 2017 Jan;102(1):79-84. doi: 10.3324/haematol.2016.149765. Epub 2016 Sep 29.

34.

Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.

Chorin E, Hochstadt A, Viskin S, Rozovski U, Havakuk O, Baranchuk A, Enriquez A, Strasberg B, Guevara-Valdivia ME, Márquez MF, González-Pacheco H, Hasdemir C, Rosso R.

Heart Rhythm. 2017 Jan;14(1):90-95. doi: 10.1016/j.hrthm.2016.09.013. Epub 2016 Sep 17.

PMID:
27650425
35.

Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Shahar T, Granit A, Zrihan D, Canello T, Charbit H, Einstein O, Rozovski U, Elgavish S, Ram Z, Siegal T, Lavon I.

J Neurooncol. 2016 Dec;130(3):413-422. Epub 2016 Aug 29.

PMID:
27573219
36.

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome.

Rozovski U, Hazan-Halevy I, Calin G, Harris D, Li P, Liu Z, Keating MJ, Estrov Z.

J Vis Exp. 2016 Jun 15;(112). doi: 10.3791/53300.

37.

At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.

Rozovski U, Harris DM, Li P, Liu Z, Wu JY, Grgurevic S, Faderl S, Ferrajoli A, Wierda WG, Martinez M, Verstovsek S, Keating MJ, Estrov Z.

J Immunol. 2016 May 15;196(10):4400-9. doi: 10.4049/jimmunol.1402108. Epub 2016 Apr 13.

38.

Craniectomy Versus Craniotomy for Posterior Fossa Metastases: Complication Profile.

Hadanny A, Rozovski U, Nossek E, Shapira Y, Strauss I, Kanner AA, Sitt R, Ram Z, Shahar T.

World Neurosurg. 2016 May;89:193-8. doi: 10.1016/j.wneu.2016.01.076. Epub 2016 Feb 4.

PMID:
26852713
39.

Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.

Rozovski U, Ben-Tal O, Kirgner I, Mittelman M, Hareuveni M.

Isr Med Assoc J. 2015 Oct;17(10):624-7.

40.

Metabolism pathways in chronic lymphocytic leukemia.

Rozovski U, Hazan-Halevy I, Barzilai M, Keating MJ, Estrov Z.

Leuk Lymphoma. 2016;57(4):758-65. doi: 10.3109/10428194.2015.1106533. Epub 2015 Dec 8. Review.

41.

Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.

Ohanian M, Bueso-Ramos C, Ok CY, Lin P, Patel K, Alattar ML, Khoury JD, Rozovski U, Estrov Z, Huh YO, Cortes J, Abruzzo LV.

Cancer Genet. 2015 Nov;208(11):571-4. doi: 10.1016/j.cancergen.2015.06.004. Epub 2015 Jun 25.

42.

Diagnostic value of T-wave morphology changes during "QT stretching" in patients with long QT syndrome.

Chorin E, Havakuk O, Adler A, Steinvil A, Rozovski U, van der Werf C, Postema PG, Topaz G, Wilde AA, Viskin S, Rosso R.

Heart Rhythm. 2015 Nov;12(11):2263-71. doi: 10.1016/j.hrthm.2015.06.040. Epub 2015 Jun 30.

PMID:
26142298
43.

Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.

Rozovski U, Benjamini O, Jain P, Thompson PA, Wierda WG, O'Brien S, Burger JA, Ferrajoli A, Faderl S, Shpall E, Hosing C, Khouri IF, Champlin R, Keating MJ, Estrov Z.

J Clin Oncol. 2015 May 10;33(14):1557-63. doi: 10.1200/JCO.2014.58.6750. Epub 2015 Apr 6.

44.

The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience.

Thompson PA, Rozovski U, Keating MJ, Stingo F, Smith SC, Wierda WG, Falchi L, O'Brien SM, Estrov Z, Burger JA, Ferrajoli A.

Br J Haematol. 2015 Oct;171(2):281-284. doi: 10.1111/bjh.13377. Epub 2015 Mar 30. No abstract available.

45.

Response.

Shahar T, Rozovski U, Ram Z.

J Neurosurg. 2015 Feb;122(2):275. No abstract available.

PMID:
25763428
46.

Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells.

Rozovski U, Grgurevic S, Bueso-Ramos C, Harris DM, Li P, Liu Z, Wu JY, Jain P, Wierda W, Burger J, O'Brien S, Jain N, Ferrajoli A, Keating MJ, Estrov Z.

Mol Cancer Res. 2015 May;13(5):944-53. doi: 10.1158/1541-7786.MCR-14-0412. Epub 2015 Mar 2.

47.

Conflicting pathology reports: a diagnostic dilemma.

Shahar T, Rozovski U, Shapira Y, Nossek E, Zelikovich B, Jossiphov J, Ram Z, Kanner AA, Siegal T, Blumenthal DT, Lavon I.

J Neurosurg. 2015 Feb;122(2):276-9. doi: 10.3171/2014.10.JNS131518. Epub 2014 Nov 28.

PMID:
25423268
48.

Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.

Ohanian M, Rozovski U, Ravandi F, Garcia-Manero G, Jabbour E, Kantarjian HM, Estrov Z.

Br J Haematol. 2015 May;169(4):595-7. doi: 10.1111/bjh.13230. Epub 2014 Nov 21. No abstract available.

49.

Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.

Rozovski U, Ohanian M, Ravandi F, Garcia-Manero G, Faderl S, Pierce S, Cortes J, Estrov Z.

Leuk Lymphoma. 2015 May;56(5):1392-7. doi: 10.3109/10428194.2014.953148. Epub 2014 Nov 3.

50.

STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis.

Li P, Harris D, Liu Z, Rozovski U, Ferrajoli A, Wang Y, Bueso-Ramos C, Hazan-Halevy I, Grgurevic S, Wierda W, Burger J, O'Brien S, Faderl S, Keating M, Estrov Z.

Mol Cancer Res. 2014 Sep;12(9):1267-82. doi: 10.1158/1541-7786.MCR-13-0652-T. Epub 2014 May 16.

Supplemental Content

Loading ...
Support Center